Skip to main content
. 2011 May 17;2011:794240. doi: 10.1155/2011/794240

Figure 4.

Figure 4

Distribution of Hematocrit (%) values at baseline and during 6 month Followup in each arm of CYTO-PV trial. The heavy dotted red line refers to the group of patients allocated to HCT < 45%; the heavy blue line refers to patients in the experimental arm (HCT 45%–50%).